We've found
						161,353
						 archived clinical trials in
						Cancer
					
				We've found
						161,353
						 archived clinical trials in
						Cancer
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
	
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
	
Updated: 7/9/2015
  
  
  	  Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
		Status: Enrolling	
	Updated: 7/9/2015
Click here to add this to my saved trials
		    
		 
	  